The Art of
Licensing 		The Art of
Development 		The Art of
Access 		The Art of
Manufacturing 		The Art of
Partnership
Home > The Art of Licensing > About Helsinn > News > 2008
2008
10.12.2008HELSINN BIREX PHARMACEUTICALS RECEIVES IMP LICENCE FOR STORAGE AND PACKAGING OF CLINICAL TRIAL MATERIALS
27.11.2008HELSINN HEALTHCARE AND ZEALAND PHARMA SIGN A PARTNERING AGREEMENT FOR ZP1846, A NOVEL GLP-2 AGONIST
12.09.2008PALONOSETRON: THE LONG-LASTING ANTIEMETIC ACTION FINDS ITS BASIS
25.08.2008HELSINN HEALTHCARE SA ANNOUNCES THE FDA’S APPROVAL OF ALOXI® (PALONOSETRON HCI) CAPSULES FOR PREVENTION OF ACUTE CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
22.07.2008SUCCESSFUL INSPECTION OF HELSINN BIREX PHARMACEUTICALS DUBLIN, IRELAND BY THE US FOOD AND DRUG ADMINISTRATION
09.07.2008HELSINN HEALTHCARE SA ANNOUNCES THE LAUNCH OF ALOXI® (PALONOSETRON HCL) INJECTION FOR THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING IN THE USA
16.06.2008POSITIVE OUTCOME TO HELSINN’S PARTICIPATION IN THE 2008 ASCO ANNUAL MEETING
08.05.2008HELSINN TO PRESENT AT THE RODMAN & RENSHAW 5th ANNUAL GLOBAL HEALTHCARE CONFERENCE MONTE CARLO, MONACO, May 19th 2008
14.04.2008HELSINN HEALTHCARE STREAMLINES QUALITY ASSURANCE GLOBALLY WITH SPARTA SYSTEMS’ TRACKWISE SOFTWARE
03.03.2008FDA APPROVES ALOXI® (PALONOSETRON HCL) INJECTION FOR PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING
20.02.2008HELSINN’S PARTICIPATION IN INFORMEX 2008
11.02.2008HELSINN HEALTHCARE SA ANNOUNCES THE LAUNCH OF ALOXI® (PALONOSETRON) IN THE UK
03.01.2008HELSINN AND MGI PHARMA ANNOUNCE sNDA FOR ALOXI CAPSULES ACCEPTED FOR REVIEW BY U.S. FDA
 
Home
Legal Statement
News
Contacts
Sitemap
Document Central
Jobs
Helsinn′s Board of Directors and Top Management
Printer Friendly
Copyright © Helsinn Group - Legal Statement
Last Update: 09.09.2010
About Helsinn Our Products Our Partners